Full text is available at the source.
The role of the gut microbiome in modulating immunotherapy efficacy in colorectal cancer
How gut bacteria may influence the success of immunotherapy in colorectal cancer
AI simplified
Abstract
Gut microbiota may significantly influence the efficacy of immunotherapy for colorectal cancer.
- Gut microbes modulate immune responses through various mechanisms, including immune cell activity and metabolite production.
- Specific gut microbes can enhance the effectiveness of immune checkpoint inhibitors by improving gut barrier function.
- The composition and diversity of gut microbiota are linked to the success of immunotherapies.
- Modifying gut microbiota could potentially improve therapeutic responses to immunotherapy.
- Strategies for manipulating gut microbiota include fecal microbial transplantation, probiotic supplementation, and dietary changes.
AI simplified